Xylazine Positivity in Opioid-positive Drug Screens on an Inpatient Labor Unit
Over 8 months, xylazine positivity significantly increased in UDSs positive for nonprescribed opioids in an urban Midwestern hospital. These results underscore the critical need to study the impact of xylazine on obstetric outcomes.
Authors
- Ebony B. Carter (ORCID: https://orcid.org/0000-0002-7620-4929)
- Stephen M. Roper (ORCID: https://orcid.org/0000-0003-3978-2858)
- Jeannie C. Kelly (ORCID: https://orcid.org/0000-0002-4908-4693)
- Bridgit Crews (ORCID: https://orcid.org/0009-0001-3535-6707)
- Nandini Raghuraman (ORCID: https://orcid.org/0000-0003-2747-5113)
- Megan L. Lawlor (ORCID: https://orcid.org/0000-0003-1298-7087)
- Vahid Azimi (ORCID: https://orcid.org/0000-0001-9204-9685)
- Antonina I. Frolova (ORCID: https://orcid.org/0000-0002-6491-6910)
- Cassandra Trammel (ORCID: https://orcid.org/0009-0007-2574-2659)
- Anthony O. Odibo
Institutions
- Washington University in St. Louis (US)
- European Brain Council (BE)
Publication Details
- Journal
- Journal of Addiction Medicine
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1097/adm.0000000000001396
- Citations
- 5
- Primary Topic
- Veterinary Pharmacology and Anesthesia
- Type
- article
- Field-Weighted Citation Impact
- 3.19